DIA
Drug Information Association Logo
« Back to Listing

The Sponsor-Vendor-Vendor Relationship: A Fine Balance

Track:
Innovative Partnering Models and Outsourcing Strategies

Day & Time:
June 18, 3:30PM - 5:00PM (Pacific Standard Time)

Session Number:
380

Room Number:
5A

Level:
Intermediate

Type:
Session

Title:
The Sponsor-Vendor-Vendor Relationship: A Fine Balance

Chair(s):
Richard J. Mayewski
Associate Director, Clinical Trial Intelligence
Novartis Pharmaceuticals Corporation, United States

Description:
This session examines the determinants of success or failure within the clinical research outsourcing environment, and offers the audience examples of ways to establish collaborative relationships in single vendor versus multi-vendor models.

Learning Objective(s):
Describe the challenges of implementing different outsourcing models including how you can overcome these in your organization; Explain when single vendor versus multi-vendor models are best utilized; Apply strategies that positively influence a successful sponsor-vendor relationship.

Presentation(s) & Speaker(s):
The Vendor Perspective
Judith Teall, RN
Director of Clinical Excellence
Exco InTouch, United Kingdom

The Sponsor Perspective
Benton Schoen
Director, Clinical Technologies, Global Clinical Development Operations
Shire Pharmaceuticals, United States

The CRO Perspective
JB Flinders, MBA, MPH
Manager, Feasibility and Recruitment Planning
ICON, United States